All stock lists
CareDx, Inc. (NASDAQ:CDNA)
US · Delayed Price · Currency is USD
Healthcare · Medical - Diagnostics & Research
69.10-0.11 (-0.16%)
Market cap
$3.57B
Health Score
Analyst consensus
Listed since
Jul 17, 2014
Website
Insider Score
––Not scored
CDNA Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
CDNA analyst forecast
CDNA analyst consensus
Moderate Buy3 ratings
Buy 2 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
CDNA 12-month price target
$74.00+7.1% upsideaverage of 1 firm
$74.00High
$74.00Low
Best analysts covering CDNA
- BTIG33%success rate · 6 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
CDNA analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-10-19 |
| BTIG | Buy | $74.00 | +36.3% | Reiterated | 2026-09-24 | |
| — | BTIG | Buy | — | — | Reiterated | 2026-08-06 |
| — | HC Wainwright & Co. | Neutral | — | — | Reiterated | 2026-07-31 |
| — | BTIG | Buy | — | — | Reiterated | 2026-07-16 |
| — | BTIG | Buy | — | — | Reiterated | 2026-04-29 |
| — | BTIG | Buy | — | — | Reiterated | 2026-02-26 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-02-25 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-12-15 |
| — | BTIG | Buy | — | — | Reiterated | 2025-11-06 |
| — | BTIG | Buy | — | — | Reiterated | 2025-09-23 |
| — | BTIG | Buy | — | — | Reiterated | 2025-09-12 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-08-08 |
| — | Craig-Hallum | Buy | — | — | Reiterated | 2025-07-18 |
| — | HC Wainwright & Co. | Neutral | — | — | Reiterated | 2025-05-05 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2025-05-05 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-04-17 |
| — | HC Wainwright & Co. | Neutral | — | — | Reiterated | 2025-03-03 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2025-02-27 |
| — | Wells Fargo | Equal Weight | — | — | Upgraded | 2025-01-15 |
| — | HC Wainwright & Co. | Neutral | — | — | Reiterated | 2025-01-14 |
| — | BTIG | Buy | — | — | Reiterated | 2024-11-05 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2024-10-16 |
| — | BTIG | Buy | — | — | Upgraded | 2024-08-19 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2024-08-01 |
| — | Craig-Hallum | Buy | — | — | Reiterated | 2024-08-01 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2024-07-17 |
| — | Craig-Hallum | Buy | — | — | Reiterated | 2024-05-17 |
| — | Raymond James | Market Perform | — | — | Downgraded | 2024-05-13 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2024-05-13 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2024-05-13 |
| — | Craig-Hallum | Buy | — | — | Reiterated | 2024-05-09 |
| — | Craig-Hallum | Buy | — | — | Upgraded | 2024-05-01 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2024-04-17 |
| — | Stephens & Co. | Overweight | — | — | Upgraded | 2023-11-09 |
| — | Stephens & Co. | Equal Weight | — | — | Reiterated | 2023-09-26 |
| — | Raymond James | Outperform | — | — | Upgraded | 2023-08-15 |
| — | Raymond James | Market Perform | — | — | Reiterated | 2023-07-11 |
| — | BTIG | Neutral | — | — | Downgraded | 2023-05-11 |
| — | Stephens & Co. | Equal Weight | — | — | Downgraded | 2023-03-07 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2023-03-07 |
| — | Craig-Hallum | Hold | — | — | Downgraded | 2023-03-03 |
| — | Raymond James | Market Perform | — | — | Downgraded | 2023-03-03 |
| — | Craig-Hallum | Buy | — | — | Reiterated | 2023-02-28 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2023-02-28 |
| — | BTIG | Buy | — | — | Reiterated | 2023-02-28 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2023-02-06 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2023-01-31 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2022-11-08 |
| — | BTIG | Buy | — | — | Reiterated | 2022-11-07 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2022-11-04 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2022-09-02 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2022-08-10 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2022-05-06 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2022-04-25 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2022-02-25 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2021-10-29 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2021-06-28 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2021-06-03 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2021-05-06 |
CDNA earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-24 | 0.02 | 0.12 | $103.3M | $108.4M |
| 2026-04-28 | 0.11 | 0.34 | $102.0M | $117.7M |
| 2026-07-30 | 0.23 | 0.37 | $114.0M | $131.9M |
| 2026-10-29 | 0.25 | 0.00 | $122.0M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.